Ivabradine
Ivabradine is a pharmaceutical drug with 67 clinical trials. Currently 4 active trials ongoing. Historical success rate of 91.4%.
Success Metrics
Based on 32 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
9
Mid Stage
42
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
78.0%
32 of 41 finished
22.0%
9 ended early
4
trials recruiting
67
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Heart Rate Control With Ivabradine on Hemodynamic in Patients With Sepsis
Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)
Ivabradine for Heart Rate Control In Septic Shock
RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)
Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM)
Clinical Trials (67)
Effect of Heart Rate Control With Ivabradine on Hemodynamic in Patients With Sepsis
Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)
Ivabradine for Heart Rate Control In Septic Shock
RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)
Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM)
Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease
Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)
Trial Assessing the Effectiveness of Ivabradine Started at Discharge From the Observation Unit
Ivabradine in Stage D Heart Failure Patients on Chronic Inotropes
Comparison Between Atenolol,Propnalol and Ivabradine
Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI
Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
Role of Ivabradine on Heart Rate and Quality of Life in Patients With Mitral Stenosis in Sinus Rhythm
Value of Heart Rate Lowering Therapy in Acute Myocarditis
Pulse Reduction On Beta-blocker and Ivabradine Therapy
Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort
IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study).
Heart Rate Controller in Computed Tomography Coronary Angiography
Clinical Study of CMR to Evaluate the Effect of Ivabradine on the Improvement of Left Ventricular Remodeling in STEMI Patients After Primary PCI
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 67